Skip to content

ENGN

enGene Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$1.91
+0.00%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
19.50x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
0.56x
Price / sales
Price / cash flow
-1.24x

Enterprise value

Enterprise value
-$105.0M
EV / sales
EV / EBITDA
0.80x
EV / EBIT
22.43x
Market cap
$128.0M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026